FindTrial
Sign In

Percutaneous pulmonary arterial denervation for treament of chronic heart failure with secondary pulmonary hypertension

Percutaneous pulmonary arterial denervation for treament of chronic heart failure with secondary pulmonary hypertension

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-12002641
Enrollment
Unknown
Registered
2012-09-21
Start date
2012-10-31
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic heart failure with secondary pulmonary hypertension

Interventions

Group 1:PADN
Group 2:PADN

Sponsors

Nanjing First Hospital, Nanjing Medical University
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Age25 mm Hg at rest; 4. NYHA II-IV;5. Left ventricular eject fraction<=40%.

Exclusion criteria

Exclusion criteria: 1. Idiopathic PAH; 2. Interstial Lung disease; 3. Connective tissue disease; 4. Chronic thromboembolic PH; 5. Portal hypertension; 6. non-left side heart failure.

Design outcomes

Primary

MeasureTime frame
6-minute walk distance;—

Secondary

MeasureTime frame
Mean PAP;Left/Right ventricular function;Hemodynamics;Repeat re-hospitalization;Survival rate;Heart transplantation;NT-BNP;ET-1;AN;—

Countries

China

Contacts

Public ContactShao_liang Chen
chmengx@126.com+86 13605157029

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026